98 related articles for article (PubMed ID: 15129189)
1. The "dark side" of endocannabinoids: a neurotoxic role for anandamide.
Cernak I; Vink R; Natale J; Stoica B; Lea PM; Movsesyan V; Ahmed F; Knoblach SM; Fricke ST; Faden AI
J Cereb Blood Flow Metab; 2004 May; 24(5):564-78. PubMed ID: 15129189
[TBL] [Abstract][Full Text] [Related]
2. Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways.
Movsesyan VA; Stoica BA; Yakovlev AG; Knoblach SM; Lea PM; Cernak I; Vink R; Faden AI
Cell Death Differ; 2004 Oct; 11(10):1121-32. PubMed ID: 15375383
[TBL] [Abstract][Full Text] [Related]
3. Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour.
Maccarrone M; Valverde O; Barbaccia ML; Castañé A; Maldonado R; Ledent C; Parmentier M; Finazzi-Agrò A
Eur J Neurosci; 2002 Apr; 15(7):1178-86. PubMed ID: 11982628
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
Veldhuis WB; van der Stelt M; Wadman MW; van Zadelhoff G; Maccarrone M; Fezza F; Veldink GA; Vliegenthart JF; Bär PR; Nicolay K; Di Marzo V
J Neurosci; 2003 May; 23(10):4127-33. PubMed ID: 12764100
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes.
Vignali M; Benfenati V; Caprini M; Anderova M; Nobile M; Ferroni S
Glia; 2009 May; 57(7):791-806. PubMed ID: 19031444
[TBL] [Abstract][Full Text] [Related]
6. Anandamide-induced cell death: dual effects in primary rat decidual cell cultures.
Fonseca BM; Correia-da-Silva G; Teixeira NA
Placenta; 2009 Aug; 30(8):686-92. PubMed ID: 19560819
[TBL] [Abstract][Full Text] [Related]
7. Anandamide induces necrosis in primary hepatic stellate cells.
Siegmund SV; Uchinami H; Osawa Y; Brenner DA; Schwabe RF
Hepatology; 2005 May; 41(5):1085-95. PubMed ID: 15841466
[TBL] [Abstract][Full Text] [Related]
8. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1).
McVey DC; Schmid PC; Schmid HH; Vigna SR
J Pharmacol Exp Ther; 2003 Feb; 304(2):713-22. PubMed ID: 12538826
[TBL] [Abstract][Full Text] [Related]
10. The contribution of VR1 and CB1 receptors and the role of the afferent vagal pathway in modelling of cardio-respiratory effects of anandamide in rats.
Kopczyńska B
Life Sci; 2007 Apr; 80(19):1738-45. PubMed ID: 17379256
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-β and in the cortex of aged rats.
Tanveer R; Gowran A; Noonan J; Keating SE; Bowie AG; Campbell VA
J Biol Chem; 2012 Oct; 287(41):34709-21. PubMed ID: 22891244
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol-dependent modulation of type 1 cannabinoid receptors in nerve cells.
Bari M; Paradisi A; Pasquariello N; Maccarrone M
J Neurosci Res; 2005 Jul; 81(2):275-83. PubMed ID: 15920744
[TBL] [Abstract][Full Text] [Related]
13. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
[TBL] [Abstract][Full Text] [Related]
14. VR1-mediated depressor effects during high-salt intake: role of anandamide.
Wang Y; Kaminski NE; Wang DH
Hypertension; 2005 Oct; 46(4):986-91. PubMed ID: 16144988
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells.
Eljaschewitsch E; Witting A; Mawrin C; Lee T; Schmidt PM; Wolf S; Hoertnagl H; Raine CS; Schneider-Stock R; Nitsch R; Ullrich O
Neuron; 2006 Jan; 49(1):67-79. PubMed ID: 16387640
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
Maccarrone M; Finazzi-Agró A
Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
[TBL] [Abstract][Full Text] [Related]
17. Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion.
Szoke E; Czéh G; Szolcsányi J; Seress L
Neuroscience; 2002; 115(3):805-14. PubMed ID: 12435419
[TBL] [Abstract][Full Text] [Related]
18. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition.
Nakajima Y; Furuichi Y; Biswas KK; Hashiguchi T; Kawahara K; Yamaji K; Uchimura T; Izumi Y; Maruyama I
FEBS Lett; 2006 Jan; 580(2):613-9. PubMed ID: 16406050
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
